4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Benign Neoplasms in 1 studies
4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hereditary thrombocytopenia is a heterogeneous group of congenital disorders with a wide range of symptoms depending on the severity of platelet dysfunction or thrombocytopenia." | 1.72 | Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. ( Jeong, DJ; Kim, MJ; Kwon, S; Kwon, SR; Lee, DS; Lee, YE; Park, JH; Yun, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, SR | 1 |
| Kim, MJ | 1 |
| Lee, YE | 1 |
| Yun, J | 1 |
| Jeong, DJ | 1 |
| Park, JH | 1 |
| Kwon, S | 1 |
| Lee, DS | 1 |
1 other study available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Benign Neoplasms
| Article | Year |
|---|---|
Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm.
Topics: Disease Susceptibility; Humans; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; | 2022 |